Currently no disease-modifying or neuroprotective treatments exist for MSA, nor are there effective medications to treat the cerebellar ataxia in MSA-C or the parkinsonian features in MSA-P. Physical ...
Multiple system atrophy (MSA) is an adult-onset, rapidly progressive neurodegenerative disorder characterised by the aggregation of α-synuclein in oligodendroglial cytoplasmatic inclusions.1 ...
At the ongoing International Conference on Alzheimer’s and Parkinson’s Diseases and Related Neurological Disorders (AD/PD 2026) in Copenhagen, researchers presented details on a new SERCA inhibitor ...
Dr. Claudio M. de Gusmao: A 69-year-old man was evaluated in the neurology clinic of this hospital because of progressively worsening ataxia. The patient had been well until 9 years before this ...
MELBOURNE, Australia and SAN FRANCISCO, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing ...
(Cerebellar means “of the cerebellum” and is the sister word to cerebral, which means “of the cerebrum.") In his review, Fyfe highlights two recent studies which have identified distinctive patterns ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results